Law360
Assessing FDA Pathways For Genome-Edited Plant Foods
March 21, 2024
In February, the U.S. Food and Drug Administration clarified the regulatory pathway for foods produced from genome-edited plants in the form of a final guidance issued by the agency's Center for Food Safety and Applied Nutrition and Center for Veterinary Medicine, titled "Foods Derived from Plants Produced Using Genome Editing." In this article, Sidley analyzes the paths forward that are available.
Contacts
Capabilities
Suggested News & Insights
Sidley Sponsors the 2026 EU Pharma Law ForumTuesday, May 19, 2026 – Thursday, May 21, 2026Women’s Life Sciences Network – Biotech Act: Funding and Investment OpportunitiesTuesday, May 19, 2026Growth Meets Guardrails: Getting You Ready for the New Realm of Ad/PromoWednesday, May 13, 2026Nineteen Sidley Lawyers Named Finalists for the Women in Business Law Americas Awards 2026April 2, 2026FDA's Crackdown On Drug Ads Conflicts With PrecedentApril 2, 2026Sixteen Sidley Partners Selected to Serve on Law360’s 2026 Editorial BoardsMarch 30, 2026
- Stay Up To DateSubscribe to Sidley Publications
- Follow Sidley on Social MediaSocial Media Directory

